Abstract
Introduction

Nerve growth factor (NGF) is a protein secreted by various neuron targets during development in both peripheral tissues and central nervous system. It is an important factor that controls the proliferation, differentiation, migration, survival and death of neuronal cells [1]. This protein exerts its physiological function through binding to its specific receptor (Trk A) which is a single-transmembrane receptor tyrosine kinase [2]. Numerous signal transduction path ways are triggered upon activation of Trk A by NGF and could be roughly classified into two categories: the small-GTPase pathway and the phospholipids pathway. Among all the pathways triggered by activated Trk A, the phosphoinositide-3-kinases (PI3K)/Akt pathway is critical for NGF to maintain neuronal cell survival. PI3Ks are lipid kinases that phosphorylate phosphatidylinositol (PI) and its derivatives phosphatidylinositol-4-phosphate (PI-4-P) and phosphatidylinositol-4,5-biphosphate (PI-4,5-P 2 ) to give phosphatidylinositol-3-phosphate (PI-3-P), phosphatidylinositol-3,4-biphosphate (PI-3,4-P
) and phosphatidylinositol 4, 4, ) , respectively. They are heterodimers composed of a catalytic subunit (p110) and a regulatory subunit (p85). The kinases are grouped into three classes (classes I, II and III) based on their sequence homologies and substrate preferences [3] . Upon Trk A activation, classes IA PI3K is recruited to the intracellular tail of Trk A via adaptor proteins like Shc and Gab1 [4, 5] where they phosphorylate the PI into various inositol phospholipids. The conversion of PI to 4, [6] . The major function of Akt is to promote growth factor-mediated cell survival and to block apoptosis via phosphorylating a great variety of proteins. For example, Akt phosphorylates proteins in the Bcl-2 and caspases families, suppressing apoptosis initiation [7, 8] . It has also been reported that transcription factors like Forkhead (FoxO) family members and nuclear factor-B (NF-B) were substrates of Akt which suggested that Akt could regulate cell survival through interacting with the transcription factors that are responsible for apoptotic gene transcription [9, 10] .
by class I PI3Ks have been studied most extensively because the PI-3,4,5-P 3 is an important intracellular messenger that binds to the pleckstrin homology (PH) domain of a great variety of proteins and activates downstream effector molecules for further signal conduction. Nowadays, more than hundreds of proteins are found to posses the PH domains. Akt (protein kinase B) is one of the wellknown examples of such PH-containing proteins. Akt is a serine/threonine kinase which belongs to the cAMP-dependant protein kinase A/protein kinase G/protein kinase C (AGC) superfamily
Because the PI3Ks were found predominately in the cytosol, most attentions were drawn to delineate the signal transduction pathway involving the cytosolic PI3Ks. Since the first report by Neri et al. [11] it is now obvious that the translocation of PI3K from cytoplasm to nucleus is a common phenomenon in several cell types [12] [13] [14] [15] [16] . The generation of 4, by PI3K in the nucleus promotes cell survival in a transcription-independent manner which inhibits the caspase-3-activated DNA fragmentation factor/ Caspase-activated DNase (DFF40/CAD) [17] . It is also found that nuclear PI-3,4,5-P 3 activates nucleophosmin/B23 which in turn prevents the apoptotic DNA fragmentation [18] . In fact, nuclear phiosphoinositid lipids are important in regulating cell proliferation and differentiation [19, 20] [21, 22] .
PIKE-S contains three praline-rich domains (PRD) at the N-terminus, followed by a GTP-binding motif (the GTPase region) and a PH domain. PIKE-L is the longer isoform of PIKE-S which possesses an extra C-terminal extension that includes a domain showing sequence homology to ARF/GAP protein (Arf-GAP) and two ankyrin repeats (ANK). PIKE-A shares identical structure with PIKE-L at the C-terminal but differ at the N-terminal that PIKE-A has no PRD.
Although the PIKEs are generated from the same gene, their tissue distribution and cellular localization are different. Northern blot analysis and immunoblotting using a specific antibody against the N-terminal showed that PIKE-S was found prominently in brain [23] . Moreover, in situ hybridization showed that PIKE-S was expressed exclusively in the neurons of cortex, hippocampus and cerebellum. The highest level was found in both CA1 region of hippocampus and the dentate gyrus. Low intensity signal was detected in the molecular layer of cerebellum, but enriched in granule and Purkinje cells [23] . Further studies using immunofluorescent staining and cellular fractionation techniques revealed that PIKE-S was nuclear specific [23] .
Like PIKE-S, PIKE-L is also brain specific. Although PIKE-S and PIKE-L could be found in the cortex, hippocampus and olfactory bulb, no PIKE-L was found in cerebellum as shown in the Western blot analysis [21] . Using [24] [25] [26] . Within the brain region, PIKE-A was detected in cerebellum, cerebral cortex, occipital pole, frontal lobe, temporal lobe and putamen [26] . Similar to PIKE-L, PIKE-A was found both in the cytoplasm and the nucleus of in transfected COS-7 cells [26] . In our evaluation of PIKE amplification in the human glioblastoma multi-form, we found that PIKE-A but not -L or -S isoform is selectively overexpressed. Interestingly, the selectively overexpressed PIKE-A provokes cancer cell survival and invasion [22, 27] . Most recently, we found that PIKE-A act as a proto-oncogene, eliciting NIH3T3 cell transformation [28] . Thus, PIKE-A might contribute to tumourgenesis.
How different PIKE isoforms are shuttled and confined to specific cellular compartment is unknown. [29] . Proteins that carry a NLS could be recognized by importin/karyopherins which are subsequently transported into the nucleus via the nuclear pore complex [30] [35] . By using yeast two hybrid screening, it was found that PIKE-S specifically bound to the C-terminal portion of 4.1N [23] .
NGF treatment of PC12 cells also stimulated translocation of 4.1N from cytoplasm to nucleus where it bound to PIKE-S [23]. Within the nucleus, 4.1N serves as the negative regulator of PIKE-S in which its PI3K activity enhancer function is abolished. It was shown that the binding of PIKE-S and PI3K in PC12 cells was abolished in the presence of 4.1N as both 4.1N and PI3K interacted with PIKE-S on the same N-terminal site [23]. It was also found that the interaction of PIKE-S and 4.1N in PC12 cells increased after NGF treatment [23]. Taken into consideration that the temporal profile of this NGF-stimulated interaction between PIKE-S and 4.1N lags behind that of PIKE-S and PI3K (24 hrs versus 30 min), the negative regulatory role of 4.1N is therefore definite. Within minutes following NGF treatment, cytosolic PI3K is transported into the nucleus where it is activated by PIKE-S. Hours later, 4.1N is translocated into the nucleus where it binds to PIKE-S and diminishes the PI3K activities by displacing the PI3K from PIKE-S (Fig. 2, Table 1). To turn off the activity of nuclear PI3K, protein 4.1N might ensure the NGFtreated cells to be primed for cell-cycle arrest and trigger PC12 differentiation, since persistent PI3K activity has been shown to block PC12 differentiation.
It is well known that exchange of GDP to GTP in the GTP-binding site of a GTPase requires the association of a guanine nucleotide exchange factor (GEF) [31] . PRD typically binds to SH3 domains of other protein [36, 37] 
. Thus the PRD in PIKE-S might serve as an interacting domain with other regulatory protein to PIKE-S function. Using an in vitro binding assay, it was found that the PRD of PIKE-S bound to the SH3 domains of a variety of proteins including
Fyn, Grb2 and phospholipase C␥1 (PLC-␥1) [38] . [39, 40] . PLC-␥1 is a well-characterized substrate of many growth factor receptor kinases to perform the proliferation and differentiation [41, 42] (Fig. 2) .
However, only PLC-␥1 but not Fyn or Grb2 enhanced the GTP-binding or GDP dissociation of PIKE-S. This interaction was strongly enhanced in PC12 cells after stimulated by NGF, indicating that the PLC-␥1 played an important role in NGF mediated PIKE-S activation. Indeed, a functional PLC-␥1 was essential for PIKE-S signaling since the expression of a SH3 domain-deleted PLC-␥1 in PC12 cells greatly diminished the NGF triggered PIKE-S activation. Notably, the activation of PIKE-S by PLC-␥1 was independent of its lipase activity since the lipase-inactive mutant of PLC-␥1 displayed similar effect as its wild-type in PIKE-S activation. These results provide a mechanistic explanation to the mitogenic activity of PLC-␥1 which is independent of its lipase activity but requires its SH3 domain
Previous studies reported that mGluR-I activation by its agonist prevent neuronal apoptosis via an unknown mechanism [54, 55] . The activation of PI3K by quisqualate-stimulated mGluR-I via PIKE-L therefore provides an explanation to this phenomenon. In hippoacmpal cultures, quisqualate stimulation prevented staurosporine-induced apoptosis [21] . [57] . Genetic studies indicated that merlin is encoded by the NF2 gene in which loss or mutation of the gene was responsible for the type 2 neurofibromatosis with schwannomas developed on or around the eighth cranial nerves [58] . It is now recognized that the mutation on NF2 gene is not restricted to schwannomas but also extended to thyroid carcinomas, hepatocellular carcinomas and perineurial tumours [59] [60] [61] [62] 
In contrast, hippocampal neurons that over-expressing PIKE-L reduced the staurosporine elicited apoptosis which demonstrated the anti-apoptotic action of PIKE-L. This anti-apoptotic action of PIKE-L depended on its ability to activate the PI3K as no protective action was seem in neurons over-expressing the PIKE-L mutant PIKE-L-KS. When the neurons are infected with PIKE-L(P187L), a mutant that abolishes the interaction between Homer and PIKE-L which has no effect on the PI3K activation, the anti-apoptotic function of quisqualate was abolished. Furthermore, pretreatment of neurons with penetratin 1 conjugated peptide that disrupted the binding of PIKE-L and Homer abrogated the anti-apoptotic function of quisqualate. All these experiments suggested that mGluR-I stimulation of PI3K and prevention of apoptosis are mediated by interactions of mGluR-I, Homer, PIKE-L and PI3K. In addition to promoting neuronal survival, PIKE-L/Homer/PI3K signaling might also implicate a variety of mGluRmediated cellular activities including synaptic plasticity, learning and memory formation. However, whether PIKE-L exerts its neuroprotective effects against neuronal excitotoxicities such as glutamate stress in vivo remain unknown. We strongly believe our on-going PIKE knockout mice studies will elucidate all these activities. which shows structure homology to the proteins of the ezrin-eadxin-moesin (ERM) family which belong to the 4.1 protein superfamily
. In genetically manipulated rat schwannoma cells RT4-D6P2T which contained inducible expression of merlin, the N-terminal of PIKE-L bind specifically to the N-terminal domain of merlin [56]. Interestingly, both merlin and Homer 1c shared the same binding site in the Nterminal of PIKE-L. On the other hand, the patientderived missense mutation (L64P) within the N-terminal of merlin failed to interact with PIKE-L. The binding of merlin to PIKE-L leads to a diminished PIKE-L-enhanced PI3K activity, which was a result of binding site competition. In fact, this PI3K displacement from PIKE-L accounts for the anti-proliferative activity of merlin. In merlin over-expressed RT4-D6P2T cells, infection with adenovirus expressing PIKE-L reduced the anti-proliferation effect induced by merlin. This effect, however, could not be detected in cells infected with mutated PIKE-L (P187L) that showed no interaction with merlin. Over-expression of merlin also enhanced the caspase-3 activity which indicated that merlin expression could increase cell death. It has been reported that transfection of merlin into human schwannoma cells decreased the cell growth by inducing apoptosis [63]. Although the studies in merlin deficient cells revealed its important role in suppressing cell growth [64], the mechanism by which merlin acts as a tumour suppressor is not obvious. Recent work suggests that its function might come from the negative regulation of PAK1 or
Rho/Rac GTPase [65, 66] [29] (Fig. 1) .
suggested that the PH domain in PIKE-L acted as a regulatory domain in which the binding of phosphoinositol changed its cellular localization as well as the GTPase activity. In vitro binding assay using agaroseconjugated phosphoinositols revealed that the PH domain of PIKE-L bound preferentially to PI-3,4,5-P 3 followed by PI-3,5-P 3 , PI-3,4-P 3 [29]. The PH domains in PIKE-S and PIKE-A showed different phosolipid binding patterns. PH domain of PIKE-S did not bind to any phosphoinositol whereas PH domain of PIKE-A strongly bound to all phosphoinositols tested. This distinct binding affinity in different PIKE isoforms could be accounted by their structural variation in the PH domain. When compared with that of PIKE-L, the PH domain of PIKE-S is truncated which composed of the first 75 amino acid of PIKE-L PH domain. On the other hand, PH domain from PIKE-A omits 20 amino acids in the C-terminal which is the result of an exon skipping during transcription
The presence of all PIKE-L structural domains is not necessary for its GTPase activity as the GTPbinding domain of PIKE-L alone possesses intrinsic enzymatic activity [29]. However, occurrence of other structural domains together with the GTP-binding motif would greatly enhance its GTPase activity. It was found that the addition of Arf-GAP domain markedly increased its hydrolytic activity. This activity could also be increased when PI-3,4,5-P 3 binds to the PH domain. Taken together, these observations suggest that phosphatidylinositol lipids may regulate PIKE-L conformation through the PH domain, leading to the C-terminal Arf-GAP domain accessible to its GTPase domain and accelerating its GTPase acivity. In fact, similar finding has been reported by
Xia et al. [26] that the Arf-GAP domain has a regulatory effect to the GTPase activity of PIKE-A.
Not only the GTPase activity of PIKE-L but also its cellular localization is regulated by the phosphatidylinositol. Surprisingly, the PH domain of PIKE-L was exclusively distributed in the nucleus but the full-length PIKE-L was predominantly located in the nucleus with small amount found in the cytoplasm [29] .
Mutation of the consensus amino acid of the PH domain (K679,687N) which abrogated its phosphatidylinositolbinding activity redirected the PIKE-L into the cytoplasm. It is therefore suggested that nuclear phosphoinositol lipids might tether PIKE-L in the nucleus thorough binding to the PH domain. However, such mutation in the PH domain of PIKE-A did not alter its cytoplasmic localization. In fact, sequence analysis revealed that PH domain in rat PIKE-L contained two NLS motifs. The first one locates between amino acid 679 to 692 which is conserved in both PIKE-A and PIKE-L and the second lies between amino acid 847 to 866 which is absent from PIKE-S and PIKE-A. Because the PH domain from PIKE-A resided exclusively in the cytoplasm, it was suggested that integrity of both NLS motifs is necessary for PIKE nuclear localization. Results from the mutation studies of the PH domain in PIKE-L further supported this idea as the K679,687N
mutant disrupted the first NLS [29] . Nevertheless, it is noteworthy that PIKE-S, the PIKE isoforms which contains truncated PH domain, is nuclear specific [23] . [24, 25] . Previous studies only concentrated on its tissue distribution as well as its GTPase activity [26] . However, it has been noted that amplification of gene locus that including the CENTG1 and CDK4 (cyclin-dependent-kinase 4) sequences was frequently observed in sarcomas and brain tumours [25] . Ahn et al. [22, 27] [27] . [70] .
Apparently, the PH domain is not the sole factor that controls the cellular localization of PIKEs and other structural domain in the N-terminal of PIKE-S might play roles in confining its cellular localization.
Anti-apoptotic activity of PIKE-A in cancers
PIKE-A cDNA has been identified a decade ago but its function remained unknown until its isoform PIKE-S was isolated
The anti-apoptotic role of PIKE-A was further confirmed from the studies using the cells whose endogenous PIKE-A is not detectable (In SF763 and LN229). In these cells, over-expressing PIKE-A remarkably inhibited staurosporine-induced apoptosis [27]. Moreover, knocking down of PIKE-A caused more cells with apoptotic features in cells with normal PIKE-A copy number than those with PIKE-A amplification [27]. The findings that expression of PIKE-A and p110␣ catalytic subunit of PI3K were significantly enhanced in primary glioblastomas further support the role of PIKE-A and PI3K in the molecular pathogenesis of primary glioblastomas
Unlike PIKE-L and PIKE-S, PIKE-A is not able to bind and activate PI3K because of the absence of the N-terminal domains which are necessary for PI3K interaction [23] . Therefore [22] . In non-cancerous cells, the interaction of PIKE-A and Akt was growth factor dependent which suggested that PIKE-A only interacted with activated-Akt. Moreover, this interaction was GTP dependent as GTP pre-treatment of GST-PIKE-A strongly enhanced its interaction with Akt [22] . Further studies using in vitro binding assay suggested that PIKE-A interacted with activated Akt through its extreme N-terminus (amino acid and a portion of the GTPase domain [61] . Interestingly, the GTPase domain alone was sufficient to bind Akt and was influenced by neither the presence of GTP nor the Akt activation [22] [74, 75] , it is thus reasonable to speculated that PIKE might play a role in this process. This hypothesis is further supported by the fact that mGluR-I, the binding partner of PIKE-L, contribute to at least one form of activity dependent synaptic plasticity [76] . [77] . Indeed, the function of insulin in brain is multivalent which includes the control of neurotransmitter receptor activity, neuronal-outgrown and cellular survival [78] [79] [80] 
